Position in ILMN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,353,605
-$4,671,277 QoQ
Shares Held
19,073
-68.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#287
of 918 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Massar Capital Management, LP holds $9,813,886 across 6 Diagnostics & Research names. ILMN ranks #1 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
This page
|
19,073 | $3,353,605 | |
| 2 | DGX |
Quest Diagnostics Inc
|
10,637 | $2,254,512 | |
| 3 | LH |
Labcorp Holdings Inc.
|
8,003 | $2,240,840 | |
| 4 | VCYT |
Veracyte, Inc.
|
14,149 | $830,970 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
1,220 | $646,099 | |
| 6 | NEO |
Neogenomics Inc
|
33,438 | $487,860 |
All Filings in ILMN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,353,605 | 19,073 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $8,024,882 | 60,053 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||